Alpine Immune Sciences In... (ALPN)
NASDAQ: ALPN
· Real-Time Price · USD
64.97
0.01 (0.02%)
At close: May 17, 2024, 10:00 PM
Alpine Immune Sciences Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -35.93 | 48.25 | -12.02 | -9.39 | -8.34 | -4.47 | -4.47 | -3.56 | -9.02 | -6.65 | -4.89 | -4.88 | -5.94 |
PEG Ratio | 0.09 | -0.34 | 1.08 | -0.54 | 0.19 | -1.79 | 0.13 | -0.03 | 0.17 | 1.22 | -0.25 | -2.19 | -0.09 |
PS Ratio | 366.24 | 37.28 | 56.12 | 57.48 | 39.12 | 121.48 | 27.17 | 48.77 | 19.92 | 89.10 | 30.98 | 29.91 | 78.97 |
PB Ratio | 7.74 | 3.51 | 3.49 | 2.92 | 2.17 | 1.88 | 1.25 | 2.59 | 2.35 | 3.34 | 2.15 | 4.91 | 4.75 |
P/FCF Ratio | -92.94 | -60.27 | -35.67 | -26.89 | -13.99 | -19.95 | -13.86 | -15.85 | 50.06 | -27.31 | 8.75 | -14.63 | -15.8 |
P/OCF Ratio | -93.01 | -60.63 | -35.68 | -27.3 | -14.04 | -20.09 | -13.91 | -16.06 | 49.83 | -27.4 | 8.75 | -14.66 | -15.84 |
OCF/S Ratio | -3.94 | -0.61 | -1.57 | -2.11 | -2.79 | -6.05 | -1.95 | -3.04 | 0.40 | -3.25 | 3.54 | -2.04 | -4.98 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.06 | 0.06 | 0.08 | 0.08 | 0.09 | 0.17 | 0.16 | 0.16 | 0.17 | 0.51 | 0.42 |
Quick Ratio | 9.56 | 7.86 | 3.81 | 3.89 | 3.48 | 4.16 | 3.70 | 2.75 | 2.58 | 2.76 | 2.87 | 2.32 | 2.32 |
Current Ratio | 9.56 | 7.86 | 3.81 | 3.88 | 3.48 | 4.16 | 3.70 | 2.75 | 2.58 | 2.75 | 2.87 | 2.32 | 2.32 |
Asset Turnover | 0.02 | 0.08 | 0.04 | 0.03 | 0.04 | 0.01 | 0.03 | 0.02 | 0.06 | 0.02 | 0.04 | 0.05 | 0.02 |
Interest Coverage | n/a | n/a | n/a | -559.11 | -222.74 | -234.13 | -131.73 | -126.84 | -48.42 | -86.38 | -65.33 | -49.22 | -48.34 |
Return on Equity | -0.05 | 0.02 | -0.07 | -0.08 | -0.06 | -0.11 | -0.07 | -0.18 | -0.07 | -0.13 | -0.11 | -0.25 | -0.2 |
Return on Assets | -0.05 | 0.02 | -0.05 | -0.05 | -0.04 | -0.07 | -0.04 | -0.08 | -0.03 | -0.06 | -0.06 | -0.07 | -0.08 |
Return on Invested Capital | -0.07 | n/a | -0.08 | -0.08 | -0.06 | -0.09 | -0.06 | -0.12 | -0.04 | -0.08 | -0.08 | -0.1 | -0.12 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -2.19 | 1.00 | 0.99 | 0.98 | 0.99 | 0.95 | 0.98 | 0.97 | 0.99 | 0.97 | -1.15 | -1.03 | -2.26 |
Net Profit Margin | -2.55 | 0.19 | -1.17 | -1.53 | -1.17 | -6.8 | -1.52 | -3.42 | -0.55 | -3.35 | -1.58 | -1.53 | -3.32 |
Pretax Profit Margin | -2.55 | 0.20 | -1.17 | -1.53 | -1.41 | -6.6 | -1.59 | -3.08 | -0.55 | -3.41 | -1.58 | -1.52 | -3.32 |
Operating Profit Margin | -3.23 | 0.05 | -1.45 | -1.82 | -1.66 | -7.34 | -1.65 | -3.12 | -0.55 | -3.39 | -1.56 | -1.49 | -3.27 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -3.21 | 0.05 | -1.15 | -1.51 | -1.41 | -6.57 | -1.56 | -3.03 | -0.53 | -3.37 | -1.53 | -1.46 | -3.2 |